Notable Analyst Upgrades and Downgrades for Week of November 15 2021

 

Upgrades:

 

Chevron (NYSE:CVX) was upgraded by research analysts at UBS Group from a "neutral" rating to a "buy" rating in a research report issued to clients and investors on Monday, The Fly reports.

CVX has been the topic of several other research reports. JPMorgan Chase & Co. cut Chevron from an "overweight" rating to a "neutral" rating and cut their price objective for the company from $128.00 to $111.00 in a research note on Wednesday, September 15th. Wells Fargo & Company increased their price objective on Chevron from $109.00 to $115.00 and gave the stock an "equal weight" rating in a report on Monday, November 1st. Piper Sandler increased their price target on Chevron from $126.00 to $137.00 and gave the company an "overweight" rating in a research note on Friday, July 23rd. They noted that the move was a valuation call. Raymond James increased their price target on Chevron from $134.00 to $137.00 and gave the company an "outperform" rating in a research note on Monday, November 1st. Finally, Redburn Partners raised Chevron from a "neutral" rating to a "buy" rating in a research note on Thursday, July 22nd. Eleven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $120.24.

Shares of CVX opened at $114.23 on Monday. The company has a market capitalization of $220.20 billion, a P/E ratio of 22.05, a P/E/G ratio of 2.51 and a beta of 1.30. Chevron has a one year low of $81.03 and a one year high of $116.21. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.03 and a current ratio of 1.28. The stock has a 50-day moving average price of $106.25 and a 200 day moving average price of $104.42. Read more …

 

Royal Dutch Shell (OTCMKTS:RDS-A) was upgraded by research analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating in a report issued on Wednesday, FinViz reports. The brokerage currently has a $56.00 price objective on the stock, up from their previous price objective of $54.00. Scotiabank’s price objective suggests a potential upside of 22.83% from the stock’s previous close.

A number of other equities analysts also recently issued reports on the company. TD Securities started coverage on Royal Dutch Shell in a research note on Monday, October 25th. They set a “buy” rating and a $56.00 target price for the company. HSBC dropped their price objective on Royal Dutch Shell to $51.70 and set a “buy” rating for the company in a research note on Tuesday, November 9th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, Royal Dutch Shell has a consensus rating of “Buy” and a consensus target price of $53.14. Read more …

 

Gilead Sciences (NASDAQ:GILD) was upgraded by investment analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a note issued to investors on Thursday, The Fly reports.

GILD has been the subject of a number of other research reports. Royal Bank of Canada reiterated a “buy” rating and set a C$84.00 price target on shares of Gilead Sciences in a research report on Monday, August 23rd. SVB Leerink dropped their price target on Gilead Sciences from $77.00 to $75.00 and set an “outperform” rating for the company in a research report on Friday, October 29th. Zacks Investment Research upgraded Gilead Sciences from a “sell” rating to a “hold” rating and set a $72.00 price target for the company in a research report on Tuesday, August 10th. Evercore ISI reiterated a “buy” rating on shares of Gilead Sciences in a research report on Sunday, October 31st. Finally, Morgan Stanley raised their price objective on Gilead Sciences from $83.00 to $84.00 and gave the company an “overweight” rating in a report on Tuesday, October 12th. Five investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $116.36. Read more …

 

 

TJX Companies (NYSE:TJX) was upgraded by stock analysts at Morgan Stanley to a “top pick” rating in a research note issued on Thursday, The Fly reports.

A number of other analysts also recently weighed in on TJX. JPMorgan Chase & Co. upped their target price on shares of TJX Companies from $80.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, August 16th. Barclays upped their price target on shares of TJX Companies from $101.00 to $102.00 and gave the stock an “overweight” rating in a research note on Tuesday. Citigroup upped their price target on shares of TJX Companies from $75.00 to $82.00 and gave the stock a “neutral” rating in a research note on Thursday, August 19th. MKM Partners upped their price target on shares of TJX Companies from $79.00 to $87.00 and gave the stock a “buy” rating in a research note on Friday, August 20th. Finally, Zacks Investment Research upgraded shares of TJX Companies from a “hold” rating to a “buy” rating and set a $69.00 price target on the stock in a research note on Wednesday, July 21st. Five equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $80.53. Read more …

Notable Analyst Upgrades and Downgrades for Week of November 1 2021 (Part 1)

 

Upgrades:

 

Intel (NASDAQ:INTC) was upgraded by analysts at Northland Securities from an “underperform” rating to a “market perform” rating in a research note issued on Monday, PriceTargets.com reports. The firm presently has a $49.00 price target on the chip maker’s stock. Northland Securities’ price target indicates a potential downside of 0.39% from the company’s current price.

A number of other equities research analysts also recently commented on INTC. The Goldman Sachs Group restated a “sell” rating and issued a $44.00 target price (down previously from $51.00) on shares of Intel in a research report on Friday, October 22nd. Zacks Investment Research upgraded Intel from a “hold” rating to a “buy” rating and set a $58.00 target price on the stock in a research report on Friday, July 9th. Citigroup reduced their target price on Intel from $57.00 to $52.00 and set a “neutral” rating on the stock in a research report on Friday, October 22nd. Credit Suisse Group set a $80.00 price objective on Intel in a report on Friday, October 22nd. Finally, Bank of America cut their price objective on Intel from $52.00 to $45.00 and set an “underperform” rating on the stock in a report on Friday, October 22nd. Eleven equities research analysts have rated the stock with a sell rating, sixteen have given a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $56.52. Read more …

 

Merck & Co., Inc. (NYSE:MRK) was upgraded by equities researchers at Argus from a “hold” rating to a “buy” rating in a note issued to investors on Monday, Analyst Price Targets reports. The brokerage presently has a $110.00 price objective on the stock. Argus’ price objective would suggest a potential upside of 25.40% from the company’s previous close.

Other equities analysts have also recently issued reports about the company. Morgan Stanley lifted their price objective on Merck & Co., Inc. from $88.00 to $90.00 and gave the stock an “equal weight” rating in a report on Friday. Barclays lifted their price objective on Merck & Co., Inc. from $87.00 to $92.00 and gave the stock an “overweight” rating in a report on Friday, October 8th. Truist began coverage on Merck & Co., Inc. in a research report on Tuesday, July 27th. They set a “buy” rating and a $92.00 price target for the company. Berenberg Bank reissued a “hold” rating and set a $92.00 price target (up previously from $86.00) on shares of Merck & Co., Inc. in a research report on Sunday, October 10th. Finally, Zacks Investment Research raised Merck & Co., Inc. from a “sell” rating to a “hold” rating and set a $82.00 price target for the company in a research report on Tuesday, August 24th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, Merck & Co., Inc. presently has an average rating of “Buy” and an average target price of $94.16. Read more …

 

Starbucks (NASDAQ:SBUX) was upgraded by research analysts at Stephens from an “equal weight” rating to an “overweight” rating in a research note issued to investors on Monday, The Fly reports. The firm currently has a $130.00 price objective on the coffee company’s stock, up from their previous price objective of $118.00. Stephens’ price objective indicates a potential upside of 22.56% from the stock’s previous close.

A number of other equities research analysts have also weighed in on the stock. Piper Sandler boosted their price objective on shares of Starbucks from $104.00 to $108.00 and gave the stock a “neutral” rating in a report on Wednesday, July 28th. Bank of America assumed coverage on shares of Starbucks in a report on Monday, October 11th. They issued a “buy” rating and a $135.00 price objective for the company. Robert W. Baird lowered their price objective on shares of Starbucks from $144.00 to $128.00 and set an “outperform” rating for the company in a report on Friday. UBS Group lowered their price objective on shares of Starbucks from $125.00 to $115.00 and set a “neutral” rating for the company in a report on Friday. Finally, Atlantic Securities downgraded shares of Starbucks from an “overweight” rating to a “neutral” rating and set a $105.00 target price on the stock. in a research note on Thursday, September 30th. Nine analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $123.00. Read more …

 

 

Sanofi (NASDAQ:SNY) was upgraded by stock analysts at HSBC from a “hold” rating to a “buy” rating in a report released on Monday, The Fly reports.

Several other brokerages have also issued reports on SNY. UBS Group reiterated a “buy” rating on shares of Sanofi in a research note on Thursday, August 12th. Morgan Stanley restated an “overweight” rating on shares of Sanofi in a research note on Friday, August 6th. Zacks Investment Research upgraded shares of Sanofi from a “hold” rating to a “buy” rating and set a $51.00 price objective on the stock in a research note on Wednesday, September 29th. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Sanofi in a research note on Thursday, October 14th. Finally, SVB Leerink upgraded shares of Sanofi from a “market perform” rating to an “outperform” rating in a research note on Monday, September 27th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $51.00. Read more …

Notable Analyst Upgrades and Downgrades for Week of September 27, 2021

 

Upgrades:

 

Sanofi (NASDAQ:SNY) was upgraded by SVB Leerink from a “market perform” rating to an “outperform” rating in a report issued on Monday, Analyst Price Targets reports.

Several other equities research analysts have also recently weighed in on SNY. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Sanofi in a report on Friday, July 30th. Morgan Stanley reissued an “overweight” rating on shares of Sanofi in a report on Friday, August 6th. Finally, UBS Group reiterated a “buy” rating on shares of Sanofi in a research report on Thursday, August 12th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $53.00. Read more …

 

The Western Union (NYSE:WU) was upgraded by equities researchers at Citigroup from a “neutral” rating to a “buy” rating in a report issued on Monday, The Fly reports.

NYSE WU opened at $20.23 on Monday. The stock has a fifty day moving average of $21.94 and a 200-day moving average of $23.70. The stock has a market capitalization of $8.22 billion, a P/E ratio of 10.32 and a beta of 0.99. The Western Union has a 52 week low of $19.07 and a 52 week high of $26.61. The company has a debt-to-equity ratio of 10.47, a quick ratio of 0.94 and a current ratio of 0.94. Read more …

 

Eli Lilly and (NYSE:LLY) was upgraded by equities researchers at Citigroup from a "neutral" rating to a "buy" rating in a note issued to investors on Wednesday, The Fly reports. The brokerage presently has a $265.00 price target on the stock, up from their prior price target of $210.00. Citigroup's price objective indicates a potential upside of 19.58% from the company's current price. The analysts noted that the move was a valuation call.

LLY has been the topic of several other research reports. Barclays upped their target price on shares of Eli Lilly and from $227.00 to $250.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 6th. The Goldman Sachs Group upped their target price on shares of Eli Lilly and from $252.00 to $270.00 and gave the stock a "conviction-buy" rating in a research note on Monday, June 14th. Cantor Fitzgerald increased their price objective on shares of Eli Lilly and from $245.00 to $300.00 and gave the company an "overweight" rating in a research report on Thursday, June 24th. Read more …

 

 

UBS Group (NYSE:UBS) was upgraded by research analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a report issued on Wednesday, The Fly reports.

Other research analysts also recently issued reports about the company. Credit Suisse Group reaffirmed an "outperform" rating on shares of UBS Group in a report on Wednesday, July 21st. Morgan Stanley reaffirmed a "hold" rating on shares of UBS Group in a report on Tuesday, August 10th. Barclays reaffirmed an "underweight" rating on shares of UBS Group in a report on Monday, July 19th. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of UBS Group in a report on Wednesday, July 21st. Finally, The Goldman Sachs Group set a $15.80 target price on UBS Group and gave the stock a "hold" rating in a report on Thursday, July 22nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $15.70. Read more …

Notable Analyst Upgrades and Downgrades for Week of September 13, 2021

 

Upgrades:

 

Bank of America (NYSE:BAC) was upgraded by stock analysts at Odeon Capital Group from a "hold" rating to a "buy" rating in a research report issued on Monday, The Fly reports. The brokerage presently has a $46.50 price target on the financial services provider's stock. Odeon Capital Group's price target indicates a potential upside of 15.47% from the stock's previous close.

Several other equities research analysts have also commented on the company. Evercore ISI restated a "buy" rating and issued a $43.00 price objective on shares of Bank of America in a research note on Friday, July 2nd. Truist Securities started coverage on Bank of America in a research note on Wednesday, June 2nd. They issued a "buy" rating for the company. Royal Bank of Canada set a $37.69 price objective on Bank of America and gave the stock a "buy" rating in a research note on Wednesday, July 21st. Credit Suisse Group upped their price objective on Bank of America from $46.00 to $47.00 and gave the stock an "outperform" rating in a research note on Friday, July 16th. Finally, Morgan Stanley upped their price objective on Bank of America from $38.00 to $42.00 and gave the stock an "underweight" rating in a research note on Thursday, July 29th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $40.42. Read more …

 

Baxter International (NYSE:BAX) was upgraded by research analysts at Cowen from a “market perform” rating to an “outperform” rating in a research report issued on Monday, The Fly reports. The brokerage presently has a $98.00 price objective on the medical instruments supplier’s stock. Cowen’s price objective suggests a potential upside of 21.11% from the company’s previous close.

BAX has been the topic of a number of other research reports. SVB Leerink reissued a “buy” rating on shares of Baxter International in a report on Sunday, September 5th. Piper Sandler reduced their price target on shares of Baxter International from $85.00 to $82.00 and set a “neutral” rating for the company in a research report on Thursday, July 29th. Stifel Nicolaus decreased their price objective on shares of Baxter International from $95.00 to $90.00 and set a “buy” rating for the company in a research note on Thursday, July 29th. Barclays upgraded Baxter International from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $93.00 to $100.00 in a research report on Friday, September 3rd. Finally, KeyCorp lowered their price objective on Baxter International from $94.00 to $92.00 and set an “overweight” rating on the stock in a report on Monday, August 2nd. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, Baxter International currently has an average rating of “Buy” and an average target price of $91.08. Read more …

 

Canadian Western Bank (TSE:CWB) was upgraded by equities research analysts at Raymond James from a "market perform" rating to an "outperform" rating in a research note issued on Monday, Price Targets.com reports. The firm currently has a C$41.00 price objective on the stock, up from their previous price objective of C$39.25. Raymond James' price target indicates a potential upside of 13.04% from the company's previous close.

CWB has been the subject of a number of other research reports. National Bankshares upped their target price on shares of Canadian Western Bank from C$40.00 to C$41.00 and gave the stock a "sector perform" rating in a research report on Monday, August 30th. Barclays upgraded shares of Canadian Western Bank from a "neutral" rating to an "overweight" rating and set a C$37.00 price objective for the company in a research report on Friday, May 28th. BMO Capital Markets increased their price objective on shares of Canadian Western Bank from C$37.00 to C$41.00 and gave the company a "market perform" rating in a research report on Monday, May 31st. Credit Suisse Group increased their target price on shares of Canadian Western Bank to C$45.00 and gave the company a "sector peform" rating in a research note on Wednesday, September 1st. Finally, CIBC increased their target price on shares of Canadian Western Bank from C$42.00 to C$44.00 and gave the company an "outperform" rating in a research note on Monday, August 30th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, Canadian Western Bank presently has a consensus rating of "Buy" and an average target price of C$41.17. Read more …

 

 

Apple (NASDAQ:AAPL) was upgraded by analysts at Oppenheimer to an “outperform” rating in a note issued to investors on Wednesday, The Fly reports. The brokerage currently has a $165.00 price target on the iPhone maker’s stock. Oppenheimer’s target price would indicate a potential upside of 11.40% from the stock’s current price.

AAPL has been the subject of a number of other reports. Jefferies Financial Group started coverage on shares of Apple in a research note on Monday. They issued a “buy” rating and a $175.00 price objective for the company. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Apple from $165.00 to $175.00 and gave the stock a “buy” rating in a report on Wednesday, July 28th. Sanford C. Bernstein reaffirmed a “hold” rating and set a $132.00 price objective on shares of Apple in a report on Tuesday, August 10th. Barclays lifted their price objective on shares of Apple from $134.00 to $142.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 28th. They noted that the move was a valuation call. Finally, Morgan Stanley lifted their target price on shares of Apple from $166.00 to $168.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 28th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and twenty-six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $160.88. Read more …

Notable Analyst Upgrades and Downgrades for Week of August 30, 2021

 

Upgrades:

 

Halliburton (NYSE:HAL) was upgraded by research analysts at COKER & PALMER from a "sector perform" rating to a "sector outperform" rating in a research note issued to investors on Monday, Zacks.com reports.

A number of other brokerages have also issued reports on HAL. BNP Paribas upgraded shares of Halliburton from an "underperform" rating to a "neutral" rating and set a $23.00 price target on the stock in a research note on Wednesday, July 21st. HSBC upgraded shares of Halliburton from a "reduce" rating to a "hold" rating and upped their target price for the stock from $15.80 to $18.20 in a research note on Thursday, August 5th. Exane BNP Paribas upgraded shares of Halliburton from an "underperform" rating to a "neutral" rating and set a $23.00 target price on the stock in a research note on Wednesday, July 21st. Barclays upped their target price on shares of Halliburton from $29.00 to $30.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 21st. Finally, Citigroup upped their target price on shares of Halliburton from $27.00 to $28.00 and gave the stock a "buy" rating in a research note on Friday, June 25th. Seven research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Halliburton currently has a consensus rating of "Buy" and a consensus price target of $23.51. Read more …

 

Apple (NASDAQ:AAPL) was upgraded by research analysts at Wolfe Research from an “underperform” rating to a “market perform” rating in a research note issued on Wednesday, The Fly reports.

AAPL has been the subject of several other research reports. Zacks Investment Research lowered shares of Apple from a “buy” rating to a “hold” rating and set a $171.00 price target for the company. in a research report on Monday, July 26th. The Goldman Sachs Group reaffirmed a “hold” rating and set a $140.00 price target on shares of Apple in a research report on Tuesday, August 10th. Canaccord Genuity upped their price target on shares of Apple from $175.00 to $185.00 and gave the stock a “buy” rating in a research report on Wednesday, July 28th. Needham & Company LLC started coverage on shares of Apple in a research report on Wednesday, July 28th. They set a “buy” rating and a $170.00 price target for the company. Finally, Loop Capital upped their price target on shares of Apple from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Wednesday, July 28th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and twenty-six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $156.74. Read more …

 

Canadian National Railway (NYSE:CNI) (TSE:CNR) was upgraded by analysts at Citigroup from a “neutral” rating to a “buy” rating in a note issued to investors on Wednesday, The Fly reports.

Several other brokerages also recently commented on CNI. Stifel Nicolaus started coverage on shares of Canadian National Railway in a research note on Monday, June 21st. They issued a “hold” rating on the stock. CIBC reduced their target price on shares of Canadian National Railway from C$146.00 to C$145.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 14th. Vertical Research upgraded shares of Canadian National Railway from a “hold” rating to a “buy” rating in a research note on Tuesday, May 18th. Wells Fargo & Company reduced their target price on shares of Canadian National Railway from $120.00 to $119.00 and set an “equal weight” rating on the stock in a research note on Friday, July 9th. Finally, Scotiabank upgraded shares of Canadian National Railway from a “sector perform” rating to an “outperform” rating in a research note on Thursday, May 27th. Ten research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, Canadian National Railway currently has an average rating of “Buy” and an average price target of $133.87. Read more …

 

 

PPL (NYSE:PPL) was upgraded by equities researchers at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating in a research note issued on Wednesday, The Fly reports. The firm currently has a $34.00 target price on the utilities provider’s stock, up from their previous target price of $22.00. Wells Fargo & Company‘s price target would indicate a potential upside of 15.84% from the company’s current price.

Other equities analysts also recently issued reports about the company. Zacks Investment Research upgraded PPL from a “strong sell” rating to a “hold” rating and set a $30.00 target price on the stock in a research report on Wednesday, July 7th. Credit Suisse Group downgraded PPL to a “neutral” rating and increased their target price for the stock from $42.00 to $46.00 in a research report on Wednesday, August 18th. Morgan Stanley increased their target price on PPL from $32.00 to $34.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 19th. TheStreet downgraded PPL from a “b” rating to a “c+” rating in a research report on Thursday, May 6th. Finally, Tudor Pickering restated a “buy” rating on shares of PPL in a report on Wednesday, May 5th. Eight research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $35.91. Read more …

Notable Analyst Upgrades and Downgrades for Week of April 12, 2021

 

Upgrades:

 

Exxon Mobil (NYSE:XOM) was upgraded by research analysts at Raymond James from an "underperform" rating to a "market perform" rating in a research note issued on Wednesday, Analyst Price Targets reports.

XOM has been the subject of a number of other reports. UBS Group reissued a "neutral" rating and set a $62.00 price objective (up from $48.00) on shares of Exxon Mobil in a research note on Monday, March 15th. Exane BNP Paribas raised shares of Exxon Mobil from an "underperform" rating to a "neutral" rating and set a $45.50 target price for the company in a research note on Monday, February 8th. The Goldman Sachs Group restated a "buy" rating and set a $65.00 target price on shares of Exxon Mobil in a research report on Tuesday, March 16th. Wells Fargo & Company raised their price objective on Exxon Mobil from $53.00 to $65.00 and gave the stock an "overweight" rating in a report on Tuesday, March 2nd. Finally, Evercore ISI initiated coverage on Exxon Mobil in a report on Tuesday, February 23rd. They issued an "inline" rating and a $48.00 price target for the company. Two analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and eight have assigned a buy rating to the company. Exxon Mobil has an average rating of "Hold" and a consensus target price of $53.26. Read more …

 

U.S. Bancorp (NYSE:USB) was upgraded by analysts at Bank of America from an “underperform” rating to a “neutral” rating in a research report issued to clients and investors on Monday, The Fly reports. The brokerage presently has a $62.00 price objective on the financial services provider’s stock, up from their prior price objective of $58.00. Bank of America‘s price target suggests a potential upside of 8.22% from the company’s current price.

Other analysts also recently issued research reports about the company. Barclays lifted their target price on U.S. Bancorp from $61.00 to $65.00 and gave the company an “overweight” rating in a research note on Wednesday, April 7th. JPMorgan Chase & Co. raised U.S. Bancorp from a “neutral” rating to an “overweight” rating and set a $60.00 price objective on the stock in a research note on Thursday. Citigroup upgraded U.S. Bancorp from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $53.00 to $55.00 in a report on Friday, January 22nd. Jefferies Financial Group lifted their target price on U.S. Bancorp from $55.00 to $66.00 and gave the stock a “buy” rating in a report on Friday. Finally, Odeon Capital Group upgraded U.S. Bancorp from a “hold” rating to a “buy” rating in a report on Wednesday, March 24th. Six investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $54.28. Read more …

 

Magellan Midstream Partners (NYSE:MMP) was upgraded by research analysts at Wolfe Research from an "underperform" rating to a "peer perform" rating in a report issued on Wednesday, Analyst Ratings Network reports. The firm currently has a $45.00 price objective on the pipeline company's stock. Wolfe Research's price target points to a potential upside of 0.56% from the stock's current price.

MMP has been the topic of several other research reports. Morgan Stanley raised their price objective on shares of Magellan Midstream Partners from $55.00 to $58.00 and gave the company an "overweight" rating in a research report on Monday, March 29th. TheStreet lowered Magellan Midstream Partners from a "b-" rating to a "c+" rating in a research note on Friday, March 12th. Truist cut Magellan Midstream Partners from a "buy" rating to a "hold" rating and set a $44.00 price objective for the company. in a report on Tuesday, February 16th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $50.00 price objective on shares of Magellan Midstream Partners in a report on Thursday, March 18th. Finally, TD Securities cut their target price on Magellan Midstream Partners from $50.00 to $47.00 and set a "buy" rating for the company in a research note on Wednesday, February 3rd. Eleven research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. Magellan Midstream Partners currently has a consensus rating of "Hold" and a consensus target price of $48.68. Read more …

 

 

Lowe’s Companies (NYSE:LOW) was upgraded by equities researchers at Atlantic Securities from a “neutral” rating to an “overweight” rating in a note issued to investors on Wednesday, The Fly reports. The firm currently has a $240.00 price objective on the home improvement retailer’s stock. Atlantic Securities’ target price would indicate a potential upside of 20.17% from the company’s previous close.

LOW has been the topic of a number of other reports. Zelman & Associates raised Lowe’s Companies from a “hold” rating to a “buy” rating in a report on Friday, February 12th. Loop Capital upped their target price on Lowe’s Companies from $195.00 to $220.00 and gave the company a “buy” rating in a research report on Monday. Gordon Haskett upgraded Lowe’s Companies from an “accumulate” rating to a “buy” rating and set a $202.00 price objective on the stock in a research report on Wednesday, March 3rd. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell started coverage on Lowe’s Companies in a report on Monday, March 15th. They set a “buy” rating and a $195.00 target price for the company. Finally, Royal Bank of Canada lifted their target price on Lowe’s Companies from $203.00 to $206.00 in a report on Thursday, February 25th. Four analysts have rated the stock with a hold rating and thirty have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $181.65. Read more …

Notable Analyst Upgrades and Downgrades for Week of November 30, 2020 (Part 1)

 

Upgrades:

 

Wells Fargo & Company (NYSE:WFC) was upgraded by equities researchers at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research note issued on Monday, The Fly reports.

A number of other research analysts have also recently issued reports on the company. BMO Capital Markets reduced their price objective on Wells Fargo & Company from $35.00 to $31.00 and set a “market perform” rating on the stock in a research note on Friday, October 16th. DA Davidson raised Wells Fargo & Company from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $27.00 to $31.00 in a research note on Thursday, November 19th. ValuEngine raised Wells Fargo & Company from a “hold” rating to a “buy” rating in a research note on Wednesday, November 25th. Odeon Capital Group upgraded shares of Wells Fargo & Company from a “hold” rating to a “buy” rating in a report on Wednesday, September 2nd. Finally, UBS Group upgraded shares of Wells Fargo & Company from a “sell” rating to a “neutral” rating and upped their price target for the company from $21.00 to $24.00 in a report on Friday, September 11th. One equities research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and eleven have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $31.30. Read more …

 

AstraZeneca (NYSE:AZN) was upgraded by equities researchers at UBS Group from a "sell" rating to a "neutral" rating in a note issued to investors on Monday, The Fly reports.

Other equities research analysts also recently issued research reports about the company. HSBC raised AstraZeneca from a "reduce" rating to a "hold" rating in a research report on Wednesday, November 11th. Berenberg Bank initiated coverage on AstraZeneca in a research report on Tuesday, September 29th. They set a "buy" rating on the stock. Oddo Bhf raised AstraZeneca from a "reduce" rating to a "buy" rating in a research report on Wednesday, September 23rd. Finally, Morgan Stanley reaffirmed an "equal weight" rating on shares of AstraZeneca in a research report on Monday, November 23rd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company's stock. The company currently has a consensus rating of "Hold" and a consensus target price of $61.00.

AZN opened at $52.61 on Monday. AstraZeneca has a 12-month low of $36.15 and a 12-month high of $64.94. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 1.14. The business's fifty day simple moving average is $53.81 and its 200-day simple moving average is $54.53. The company has a market capitalization of $138.08 billion, a price-to-earnings ratio of 63.39, a PEG ratio of 1.63 and a beta of 0.50. Read more …

 

The Bank of New York Mellon (NYSE:BK) was upgraded by investment analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating in a note issued to investors on Monday, The Fly reports.

Several other equities analysts have also recently commented on the stock. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell cut shares of The Bank of New York Mellon from a "buy" rating to a "neutral" rating in a report on Tuesday, November 10th. Deutsche Bank Aktiengesellschaft upgraded shares of The Bank of New York Mellon from a "hold" rating to a "buy" rating and boosted their price target for the company from $39.00 to $46.00 in a report on Wednesday, November 11th. Smith Barney Citigroup cut shares of The Bank of New York Mellon from a "buy" rating to a "neutral" rating in a report on Tuesday, November 10th. Bank of America cut shares of The Bank of New York Mellon from a "neutral" rating to an "underperform" rating and lowered their price target for the company from $42.00 to $39.00 in a report on Friday, November 20th. Finally, Keefe, Bruyette & Woods cut shares of The Bank of New York Mellon from an "outperform" rating to a "market perform" rating and lowered their price target for the company from $47.00 to $43.00 in a report on Wednesday, November 18th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have assigned a buy rating to the company's stock. The Bank of New York Mellon has a consensus rating of "Hold" and an average target price of $44.56. Read more …

 

 

U.S. Bancorp (NYSE:USB) was upgraded by investment analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating in a research note issued on Monday, The Fly reports.

USB has been the subject of a number of other research reports. Bank of America raised shares of U.S. Bancorp from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $39.00 to $41.00 in a research report on Wednesday, October 7th. JPMorgan Chase & Co. raised their price target on shares of U.S. Bancorp from $37.50 to $43.50 and gave the stock an “underweight” rating in a research report on Tuesday, October 6th. ValuEngine raised shares of U.S. Bancorp from a “sell” rating to a “hold” rating in a report on Monday, November 2nd. Finally, TheStreet raised shares of U.S. Bancorp from a “c” rating to a “b-” rating in a report on Thursday, October 15th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company. U.S. Bancorp presently has a consensus rating of “Hold” and a consensus target price of $44.58. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of October 5, 2020

 

 

Upgrades:

 

ONEOK (NYSE:OKE) was upgraded by investment analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating in a research note issued on Monday, Briefing.com reports. The brokerage currently has a $36.00 price target on the utilities provider's stock. Wells Fargo & Company's price objective would suggest a potential upside of 35.70% from the company's current price.

 

OKE has been the topic of several other research reports. Argus cut ONEOK from a "buy" rating to a "hold" rating in a research report on Monday, August 3rd. Morgan Stanley lowered their target price on ONEOK from $26.00 to $25.00 and set an "underweight" rating on the stock in a research note on Friday, August 21st. Stifel Nicolaus lowered their target price on ONEOK from $38.00 to $36.00 and set a "buy" rating on the stock in a research note on Thursday, July 30th. Royal Bank of Canada boosted their price objective on ONEOK from $31.00 to $33.00 and gave the company a "sector perform" rating in a research note on Thursday, July 30th. Finally, Scotiabank cut ONEOK from a "sector outperform" rating to a "sector perform" rating and set a $31.00 target price for the company. in a research report on Monday, September 21st. Three analysts have rated the stock with a sell rating, thirteen have issued a hold rating and seven have given a buy rating to the company. The stock has an average rating of "Hold" and an average target price of $37.75. Read more …

 

Bank of Montreal (TSE:BMO) (NYSE:BMO) was upgraded by equities research analysts at Bank of America from an "underperform" rating to a "neutral" rating in a report issued on Tuesday, BayStreet.CA reports.

 

A number of other research firms have also recently weighed in on BMO. Canaccord Genuity lifted their target price on shares of Bank of Montreal from C$79.00 to C$80.50 in a research note on Wednesday, August 19th. Royal Bank of Canada boosted their price target on shares of Bank of Montreal from C$75.00 to C$86.00 and gave the stock a "sector perform" rating in a research note on Wednesday, August 26th. TD Securities boosted their price target on shares of Bank of Montreal from C$84.00 to C$87.00 and gave the stock a "buy" rating in a research note on Wednesday, August 26th. Fundamental Research restated a "buy" rating and set a C$94.07 target price on shares of Bank of Montreal in a research report on Thursday, September 3rd. Finally, Credit Suisse Group upped their target price on shares of Bank of Montreal from C$75.00 to C$81.00 in a research report on Thursday, August 27th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. The company has an average rating of "Hold" and an average price target of C$85.27. Read more …

 

Diageo (NYSE:DEO) was upgraded by analysts at Jefferies Financial Group from an "underperform" rating to a "buy" rating in a report issued on Wednesday, The Fly reports.

 

A number of other analysts have also weighed in on the stock. UBS Group restated a "buy" rating on shares of Diageo in a research report on Monday, August 10th. Bryan, Garnier & Co raised shares of Diageo from a "neutral" rating to a "buy" rating in a research note on Wednesday, July 8th. Royal Bank of Canada reaffirmed a "sector perform" rating on shares of Diageo in a research note on Thursday, August 6th. Zacks Investment Research raised shares of Diageo from a "sell" rating to a "buy" rating and set a $148.00 price target for the company in a research note on Tuesday. Finally, HSBC assumed coverage on shares of Diageo in a research note on Wednesday, July 8th. They set a "buy" rating for the company. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and nine have issued a buy rating to the company's stock. The stock currently has a consensus rating of "Hold" and an average target price of $135.50. Read more …

 

 

 

 

Anheuser Busch Inbev (NYSE:BUD) was upgraded by investment analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Briefing.com reports. Jefferies Financial Group also issued estimates for Anheuser Busch Inbev’s Q3 2020 earnings at $0.74 EPS, Q4 2020 earnings at $0.74 EPS, FY2020 earnings at $1.51 EPS, FY2021 earnings at $3.07 EPS and FY2022 earnings at $3.33 EPS.

 

Several other equities analysts have also issued reports on BUD. Evercore ISI raised shares of Anheuser Busch Inbev from an “in-line” rating to an “outperform” rating and set a $75.00 price target on the stock in a report on Thursday, July 30th. Barclays reissued an “equal weight” rating on shares of Anheuser Busch Inbev in a report on Friday, September 18th. Argus boosted their price objective on shares of Anheuser Busch Inbev from $52.00 to $62.00 and gave the company a “buy” rating in a report on Tuesday, August 18th. UBS Group reissued a “neutral” rating on shares of Anheuser Busch Inbev in a report on Thursday, July 9th. Finally, Kepler Capital Markets reissued a “buy” rating on shares of Anheuser Busch Inbev in a report on Sunday, September 6th. Four investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and eight have issued a buy rating to the company. Anheuser Busch Inbev has a consensus rating of “Hold” and an average target price of $63.00. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of August 26, 2019

Upgrades:

United Parcel Service (NYSE:UPS) was upgraded by equities research analysts at Daiwa Capital Markets from a “neutral” rating to an “outperform” rating in a report released on Monday, The Fly reports. A number of other equities analysts also recently commented on UPS. Argus restated a “buy” rating on shares of United Parcel Service in a research note on Tuesday, April 30th. Credit Suisse Group set a $119.00 price objective on shares of United Parcel Service and gave the stock a “neutral” rating in a research note on Wednesday, July 31st. UBS Group increased their price objective on shares of United Parcel Service to $128.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. Goldman Sachs Group initiated coverage on shares of United Parcel Service in a research note on Wednesday, July 10th. They set a “buy” rating and a $123.00 price objective for the company. Finally, Stifel Nicolaus cut shares of United Parcel Service from a “buy” rating to a “hold” rating and set a $118.00 target price on the stock. in a report on Monday, July 29th. One analyst has rated the stock with a sell rating, eleven have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $118.82. Read more …

Oppenheimer upgraded shares of Verizon Communications (NYSE:VZ) from a market perform rating to an outperform rating in a research report released on Tuesday, The Fly reports. The brokerage currently has $70.00 price objective on the cell phone carrier’s stock. VZ has been the topic of a number of other research reports. Citigroup lowered Verizon Communications from a buy rating to a neutral rating and set a $62.00 price objective on the stock. in a report on Monday, July 8th. Zacks Investment Research raised Verizon Communications from a hold rating to a buy rating and set a $58.00 price objective on the stock in a report on Monday, August 5th. Finally, UBS Group lowered Verizon Communications from a buy rating to a neutral rating and set a $57.70 price objective on the stock. in a report on Thursday, May 30th. They noted that the move was a valuation call. Nine research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of Hold and an average price target of $60.22. Read more …

DZ Bank upgraded shares of Pfizer (NYSE:PFE) from a sell rating to a hold rating in a report issued on Wednesday morning, The Fly reports. They currently have $36.00 price objective on the biopharmaceutical company’s stock. PFE has been the topic of a number of other research reports. JPMorgan Chase & Co. set a $46.00 price target on shares of Pfizer and gave the stock a neutral rating in a report on Monday, July 29th. Bank of America cut shares of Pfizer from a buy rating to a neutral rating in a report on Tuesday, July 30th. Morgan Stanley lowered their price target on shares of Pfizer from $40.00 to $38.00 and set an equal weight rating on the stock in a report on Tuesday. UBS Group reaffirmed a neutral rating and issued a $43.00 price target on shares of Pfizer in a report on Monday, August 5th. Finally, Barclays reaffirmed a hold rating and issued a $41.00 price target on shares of Pfizer in a report on Thursday, May 9th. Fifteen investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of $45.88. Read more …

Novo Nordisk A/S (NYSE:NVO) was upgraded by research analysts at Pareto Securities from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday, August 5th, The Fly reports. A number of other analysts also recently issued reports on NVO. Deutsche Bank downgraded shares of Novo Nordisk A/S from a “buy” rating to a “hold” rating and set a $52.42 price objective for the company. in a report on Thursday, June 20th. UBS Group reiterated a “buy” rating and set a $355.00 target price on shares of Novo Nordisk A/S in a research report on Wednesday, June 19th. Zacks Investment Research upgraded shares of Novo Nordisk A/S from a “sell” rating to a “hold” rating and set a $50.00 target price for the company in a research report on Monday, July 15th. Barclays raised shares of Novo Nordisk A/S from an “underweight” rating to an “equal weight” rating and set a $51.85 target price on the stock in a research note on Tuesday, June 11th. Finally, Credit Suisse Group upgraded shares of Novo Nordisk A/S from a “neutral” rating to an “outperform” rating in a research note on Monday, April 29th. One analyst has rated the stock with a sell rating, ten have given a hold rating and six have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $111.58. Read more …

Notable Analyst Upgrades and Downgrades for Week of July 29, 2019

Upgrades:

Anheuser Busch Inbev (NYSE:BUD) was upgraded by analysts at Bank of America from a “neutral” rating to a “buy” rating in a note issued to investors on Monday, The Fly reports. The analysts noted that the move was a valuation call.

Other equities research analysts have also issued research reports about the stock. Zacks Investment Research lowered shares of Glu Mobile from a “buy” rating to a “hold” rating in a report on Tuesday, April 9th. Barclays set a €16.80 ($19.53) price objective on shares of Deutsche Telekom and gave the stock a “neutral” rating in a report on Tuesday, April 2nd. ValuEngine lowered shares of Vereit from a “buy” rating to a “hold” rating in a report on Friday, July 19th. Finally, Argus lowered shares of Lions Gate Entertainment from a “buy” rating to a “hold” rating in a report on Thursday, May 30th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $83.77. Read more …

Gilead Sciences (NASDAQ:GILD) was upgraded by research analysts at Royal Bank of Canada from an “outperform” rating to a “top pick” rating in a report issued on Monday, The Fly reports.

A number of other equities analysts have also commented on GILD. Mizuho set a $88.00 price objective on Gilead Sciences and gave the stock a “buy” rating in a research note on Monday, July 15th. Cowen set a $150.00 price target on Tesla and gave the company a “sell” rating in a research note on Friday, May 3rd. BMO Capital Markets set a $76.00 price target on Gilead Sciences and gave the company a “buy” rating in a research note on Monday, July 15th. BidaskClub upgraded Zai Lab from a “sell” rating to a “hold” rating in a research note on Wednesday, June 5th. Finally, ValuEngine lowered Intersect ENT from a “buy” rating to a “hold” rating in a research note on Monday, July 8th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $81.09. Read more …

National-Oilwell Varco (NYSE:NOV) was upgraded by research analysts at Citigroup from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, The Fly reports.

NOV has been the topic of a number of other reports. Johnson Rice lowered National-Oilwell Varco from a “buy” rating to a “hold” rating and set a $25.00 target price on the stock. in a report on Monday, July 15th. Bank of America reaffirmed an “underperform” rating and set a $1.25 target price (down from $4.50) on shares of Superior Energy Services in a report on Tuesday, June 25th. Susquehanna Bancshares set a $23.00 target price on National-Oilwell Varco and gave the stock a “hold” rating in a report on Friday, July 19th. Raymond James reaffirmed an “average” rating and set a $23.00 target price on shares of in a report on Monday, April 15th. Finally, TheStreet lowered Weibo from a “b-” rating to a “c+” rating in a report on Friday, May 31st. Six research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and eleven have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $35.36. Read more …

Bank of America upgraded shares of Dominion Energy (NYSE:D) from an underperform rating to a neutral rating in a research note issued to investors on Thursday, June 13th, 24/7 WallStreet reports. Bank of America currently has $80.00 price target on the utilities provider’s stock, up from their previous price target of $79.00. The analysts noted that the move was a valuation call.

Several other equities analysts also recently weighed in on D. TheStreet downgraded Dominion Energy from a b rating to a c+ rating in a research report on Friday, May 3rd. Macquarie downgraded Dominion Energy from an outperform rating to a neutral rating in a research report on Monday, March 18th. They noted that the move was a valuation call. Zacks Investment Research raised Dominion Energy from a hold rating to a buy rating and set a $87.00 target price on the stock in a report on Monday, April 8th. ValuEngine cut Dominion Energy from a buy rating to a hold rating in a report on Wednesday, June 12th. Finally, Credit Suisse Group initiated coverage on Dominion Energy in a report on Friday, April 12th. They issued a neutral rating and a $78.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of Hold and an average price target of $85.54. Read more …